British Pharma Produces The Full Range Finished Products Of Biosimilar Anabolic/Androgen Hormones For Therapeutic Use Under Good Manufacturing Practice (Gmp) And World Health Organization (Who) The Products Are Produced By Our Special Raw Material Specifications; Most Of Them Are Following, British Pharmacopeias (Bp), United Pharmacopeias Europe Pharmacopeias (Ph. Eur.), Us Pharmacopeias (Usp) The Pharmacopoeias Of Japan (Jpn P.) Or Pharmacopoeias In Poland ( Pol.P.) Standard. All Of Them Are Passed Through Our Independent Quality Control Process. According To The New International And Local Fda Regulations, The Product License Is Mandatory To Be Displayed.Hence The Standard Concentrated Control As Mentioned Is Always Applied In Our Production Process With All Our Products.